Genome-wide gene expression profiles of clear cell renal cell carcinoma: Identification of molecular targets for treatment of renal cell carcinoma

International Journal of Oncology

Volumn 29, Issue 4, 2006, Pages 799-827

  Hirota, Eiji ^a,b   Yan, Liang ^a   Tsunoda, Tatsuhiko ^c   Ashida, Shingo ^a,d   Fujime, Makoto ^e   Shuin, Taro ^d   Miki, Tsuneharu ^b   Nakamura, Yusuke ^a   Katagiri, Toyomasa ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^d KOCHI MEDICAL SCHOOL   (Japan)

^e JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

cDNA microarray; Clear cell renal cell carcinoma; Expression profile; Laser microbeam microdissection

Indexed keywords

MEMBRANE PROTEIN; SEMA3B PROTEIN, HUMAN; SEMAPHORIN; SMALL INTERFERING RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; DNA MICROARRAY; DRUG ANTAGONISM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; MIDDLE AGED; RNA INTERFERENCE; TRANSACTIVATION; TUMOR CELL LINE; TUMOR GENE;

ADULT; AGED; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; KIDNEY NEOPLASMS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SEMAPHORINS; TRANS-ACTIVATION (GENETICS); TUMOR MARKERS, BIOLOGICAL;

EID: 34249016907     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.4.799     Document Type: Article

References (33)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Amato RJ: Chemotherapy for renal cell carcinoma. Semin Oncol 27: 177-186, 2000.
3. Cohen HT and McGovern FJ: Renal cell carcinoma. N Engl J Med 353: 2477-2490, 2005.
4. Walsh PC, Retik AB, Vaughan ED, Wein AJ, Kavoussi LR, Novick AC, Partin AW and Peters CA: Campbell's Urology. 8th edition. Saunders, Philadelphia, 2003.
5. Ljungberg B, Alamdari FI, Rasmuson T and Roos G: Follow-up guidelines for non-metastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy. BJU Int 84: 405-411, 1999. (Pubitemid 29419406)
6. Stephenson AJ, Chetner MP, Rourke K, Gleave ME, Signaevsky M, Palmer B, Kuan J, Brock GB and Tanguay S: Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy. J Urol 172: 58-62, 2004. (Pubitemid 41615038)
7. Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, Darson M, Delahunt B and Iczkowski K: Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contrele Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80: 987-989, 1997.
8. Nakamura T, Furukawa Y, Nakagawa H, Tsunoda T, Ohigashi H, Murata K, Ishikawa O, Ohgaki K, Kashimura N, Miyamoto M, Hirano S, Kondo S, Katoh H, Nakamura Y and Katagiri T: Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene 23: 2385-2400, 2004.
9. Ono K, Tanaka T, Tsunoda T, Kitahara O, Kihara C, Okamoto A, Ochiai K, Takagi T and Nakamura Y: Identification by cDNA microarray of genes involved in ovarian carcinogenesis. Cancer Res 60: 5007-5011, 2000.
10. Shimokawa T, Furukawa Y, Sakai M, Li M, Miwa N, Lin YM and Nakamura Y: Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the β-catenin/T-cell factor complex. Cancer Res 63: 6116-6120, 2003.
11. Togashi A, Katagiri T, Ashida S, Fujioka T, Maruyama O, Wakumoto Y, Sakamoto Y, Fujime M, Kawachi Y, Shuin T and Nakamura Y: Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma and potential target for molecular therapy. Cancer Res 65: 4817-4826, 2005.
12. Yao M, Tabuchi H, Nagashima Y, Baba M, Nakaigawa N, Ishiguro H, Hamada K, Inayama Y, Kishida T, Hattori K, Yamada-Okabe H and Kubota Y: Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma. J Pathol 205: 377-387, 2005.
13. Cheung CW, Vesey DA, Nicol DL and Johnson DW: The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation. Kidney Int 65: 1272-1279, 2004.
14. Staehler M, Rohrmann K, Haseke N, Stief CG and Siebels M: Targeted agents for the treatment of advanced renal cell carcinoma. Curr Drug Targets 6: 835-846, 2005. (Pubitemid 41472497)
15. Braybrooke JP, O'Byrne KJ, Propper DJ, Blann A, Saunders M, Dobbs N, Han C, Woodhull J, Mitchell K, Crew J, Smith K, Stephens R, Ganesan TS, Talbot DC and Harris AL: A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis. Clin Cancer Res 6: 4697-4704, 2000.
16. Niu Z, Ito M, Awakura Y, Takahashi T, Nakamura E, Ito N and Ogawa O: The expression of NOV and WT1 in renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis. J Urol 174: 1460-1462, 2005.
17. Kikuchi T, Toyota M, Itoh F, Suzuki H, Obata T, Yamamoto H, Kakiuchi H, Kusano M, Issa JP, Tokino T and Imai K: Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors. Oncogene 21: 2741-2749, 2002.
18. Watanabe H, Pan ZQ, Schreiber-Agus N, De Pinho RA, Hurwitz J and Xiong Y: Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen. Proc Natl Acad Sci USA 95: 1392-1397, 1998.
19. Evdokiou A and Cowled PA: Tumor-suppressive activity of the growth arrest-specific gene GAS1 in human tumor cell lines. Int J Cancer 75: 568-577, 1998.
20. Liou LS, Shi T, Duan ZH, Sadhukhan P, Der SD, Novick AA, Hissong J, Skacel M, Almasan A and Di Donato JA: Microarray gene expression profiling and analysis in renal cell carcinoma. BMC Urol 4: 1-9, 2004.
21. Takahashi M, Rhodes DR, Furge KA, Kanayama H, Kagawa S, Haab BB and Teh BT: Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci USA 98: 9754-9759, 2001.
22. Boer JM, Huber WK, Sultmann H, Wilmer F, von Heydebreck A, Haas S, Korn B, Gunawan B, Vente A, Fuzesi L, Vingron M and Poustka A: Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Res 11: 1861-1870, 2001.
23. Young AN, Amin MB, Moreno CS, Lim SD, Cohen C, Petros JA, Marshall FF and Neish AS: Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am J Pathol 158: 1639-1651, 2001.
24. Higgins JP, Shinghal R, Gill H, Reese JH, Terris M, Cohen RJ, Fero M, Pollack JR, van de Rijn M and Brooks JD: Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol 162: 925-932, 2003.
25. Skubitz KM and Skubitz AP: Differential gene expression in renal-cell cancer. J Lab Clin Med 140: 52-64, 2002. (Pubitemid 34703347)
26. Madi L, Ochaion A, Rath-Wolfson L, Bar-Yehuda S, Erlanger A, Ohana G, Harish A, Merimski O, Barer F and Fishman P: The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor trowth inhibition. Clin Cancer Res 10: 4472-4479, 2004.
27. Takahashi M, Papavero V, Yuhas J, Kort E, Kanayama HO, Kagawa S, Baxter RC, Yang XJ, Gray SG and Teh BT: Altered expression of members of the IGF-axis in clear cell renal cell carcinoma. Int J Oncol 26: 923-931, 2004.
28. Cheung CW, Vesey DA, Nicol DL and Johnson DW: The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation. Kidney Int 65: 1272-1279, 2004.
29. Yano Y, Hayashi Y, Sano K, Nagano H, Nakaji M, Seo Y, Ninomiya T, Yoon S, Yokozaki H and Kasuga M: Expression and localization of ecto-nucleotide pyrophosphatase/phosphodiesterase I-1 (E-NPP1/PC-1) and -3 [(E-NPP3/CD203c/PD- Ibeta/B10/gp130(RB13-6)] in inflammatory and neoplastic bile duct diseases. Cancer Lett 207: 139-147, 2004.
30. Gonzalez HE, Gujrati M, Frederick M, Henderson Y, Arumugam J, Spring PW, Mitsudo K, Kim HW and Clayman GL: Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 129: 754-759, 2003.
31. Yamamura J, Miyoshi Y, Tamaki Y, Taguchi T, Iwao K, Monden M, Kato K and Noguchi S: mRNA expression level of estrogen-inducible gene, alpha 1-antichymotrypsin, is a predictor of early tumor recurrence in patients with invasive breast cancers. Cancer Sci 95: 887-892, 2004. (Pubitemid 40045523)
32. Kolodkin AL, Matthes DJ and Goodman CS: The semaphoring genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 75: 1389-1399, 1993.
33. Tamagnone L and Comoglio PM: To move or not to move? Semaphorin signalling in cell migration. EMBO Rep 5: 356-361, 2004. (Pubitemid 38618276)